CSI is a pharmacist using expertise in the biotechnology sector to bring Alpha to your portfolio, with Buys/Strong Buys averaging 30% gains (as of July 14, 2023) since September 2022. CSI's favored investing strategy is near-term, driven by binary events such as clinical trial results, FDA Advisory Committee meetings, and PDUFA dates (approvals), but also formulary placement and prescription trends. These writings should not be considered financial advice or the sole basis for investment decisions. CSI has worked across the spectrum from very small independent and hospital pharmacies to the some of the largest retail corporations and medical centers in the nation, as well as experience in specialty, correctional, and mail order settings. Prior to a career in healthcare, CSI worked 12 years in the highest-level IT specialist position at a top state employer.

CTIC CTI BioPharma Corp.Stock Price & Overview

Analysis

News

Latest Headlines

CTIC CTI BioPharma Corp.
Stock Price & Overview